AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ROSUVASTATIN 5 Mg ;

11 registrations across 1 African market— 11 active

Markets with ROSUVASTATIN 5 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Crestatin 5 mg
Film Coated Tablets
🇪🇬EgyptAdwiaactive
Crestatin 5 mg
Film Coated Tablets
🇪🇬EgyptAdwiaactive
Cholerose 5mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Rosulipid 5 mg
Film Coated Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Advochol 5 mg
Film Coated Tablets
🇪🇬EgyptCareval for pharmaceutical industriesactive
Cemicresto 5 mg
Film Coated Tablets
🇪🇬EgyptP and C Labs - Pellets and CR Productsactive
Anticholestatin 5 mg
orally disintegrating Tablets
🇪🇬EgyptEpsilon pharmaactive
Gypravastin 5 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Gypravastin 5 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Rosulipid 5 mg
Film Coated Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Anticholestatin 5 mg
orally disintegrating Tablets
🇪🇬EgyptEpsilon pharmaactive

ROSUVASTATIN 5 Mg ; in Africa — Regulatory Overview

ROSUVASTATIN 5 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.